Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CPRX
CPRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CPRX News
Investor Rights Law Firm Investigates Multiple Companies
May 19 2026
PRnewswire
Multiple Company Sale Transactions and Shareholder Rights
May 12 2026
PRnewswire
Monteverde Law Firm Investigates Catalyst Pharmaceuticals Sale
May 11 2026
Globenewswire
Catalyst Pharmaceuticals to Announce Q1 Earnings on May 11
May 11 2026
seekingalpha
Catalyst Pharmaceuticals Agrees to $4.1B Acquisition by Angelini Pharma
May 10 2026
Yahoo Finance
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
May 08 2026
PRnewswire
Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1 Billion
May 07 2026
NASDAQ.COM
Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1 Billion
May 07 2026
Globenewswire
Hetero Labs Secures License for FIRDAPSE Generic
May 07 2026
Newsfilter
Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1 Billion
May 07 2026
Newsfilter
Italy's Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1 Billion
May 07 2026
Newsfilter
Angelini Pharma to Acquire Catalyst Pharmaceuticals for $4.1B
May 07 2026
seekingalpha
Catalyst Pharmaceuticals Settles Patent Litigation with Hetero Labs
May 07 2026
Yahoo Finance
Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1 Billion
May 07 2026
Globenewswire
Angelini Pharma to Acquire Catalyst Pharmaceuticals for $31.50 Per Share in $4.1 Billion Transaction
May 07 2026
moomoo
Angelini Pharma Evaluates Potential Acquisition of Catalyst Pharmaceuticals
Apr 27 2026
seekingalpha
Show More News
